ZOGENIX INTERNATIONAL LIMITED

Company number 08330213 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£54,488

Balance sheet as at 2013-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2012-12-13
Registered office
Windlesham Campus, Sunninghill Road, Windlesham, Surrey, England, GU20 6PP
Postcode
GU20 6PP
Capital
735 GBP
Accounts category
Full

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-05-28
Next due by
2027-06-11
View filing history →

Nature of business (SIC)

  • 74909 Other professional, scientific and technical activities not elsewhere classified

Officers 4 current · 18 resigned

Appointed 2024-12-01
Viral Rohit SHAH Director
Appointed 2022-04-29
Yogesh KHATRI Director
Appointed 2022-04-29
DR GAIL FARFEL Director
PHARMA EXECUTIVE - DEVELOPMENT Appointed 2015-12-01

View all officers and resignations →

Group structure

Controlled by Ucb Biosciences Inc. (02946509) — since 2026-01-12

Controlled by ZOGENIX EUROPE LIMITED — since 2016-04-06

From persons-with-significant-control filings on the public register.

Modern slavery statement

Registered a modern slavery statement for 2025 (period to 2025-06-30) as part of the UCB PHARMA LIMITED group statement — 3 years on the registry.

Read the statement summary on the government modern slavery statement registry. Contains public sector information licensed under the Open Government Licence v3.0.

Data protection registration

Registered with the ICO as a data protection fee payer — ZA253922 (Tier 2), registered since 2017.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
zogenix.com

UCB, a global biopharmaceutical company, has several locations. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia. Additional U.S. sites include global clinical development in Raleigh, North Carolina, our policy office in Washington, D.C., and research supporting UCB’s pipeline

Previous company names

NameDate changed
BRABANT PHARMA LIMITED2015-11-17

Previous registered addresses 6

AddressChanged on
SIENA COURT BROADWAY, MAIDENHEAD, SL6 1NJ, ENGLAND2020-03-31
11TH FLOOR WHITEFRIARS, LEWINS MEAD, BRISTOL, BS1 2NT, ENGLAND2017-04-03
SIENNA COURT BROADWAY, MAIDENHEAD, BERKSHIRE, SL6 1NJ, ENGLAND2017-03-31
11TH FLOOR WHITEFRIARS LEWINS MEAD, BRISTOL, BS1 2NT2015-12-08
74 GARTSIDE STREET, MANCHESTER, GREATER MANCHESTER, M3 3EL2015-06-23
11TH FLOOR WHITEFRIARS LEWINS MEAD, BRISTOL, BS1 2NT2015-06-23

Competitors Guildford

This company ranks 230 among other professional, scientific and technical activities not elsewhere classified in Guildford.

Full league table →

The class of 2012

26%

of the 8,880 companies in this sector incorporated in 2012 are still active today; 71% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →

Property in England & Wales 1 title

Leasehold
1
Most recent registration
2020-02-25
Where
Windsor And Maidenhead
Title numberCounty Tenure RegisteredPrice paid
BK506934 Windsor And Maidenhead Leasehold 2020-02-25

For addresses and the authoritative register entry, use HM Land Registry's official search (£3 per title).

Information produced by HM Land Registry. © Crown copyright 2026. Dataset as at 2026-08.